Boiron SA (LON:0DTF)

London flag London · Delayed Price · Currency is GBP · Price in EUR
25.60
+0.35 (1.39%)
At close: Mar 27, 2026
Market Cap391.34M +12.2%
Revenue (ttm)432.76M +4.8%
Net Income16.60M -18.2%
EPS0.96 -18.2%
Shares Outn/a
PE Ratio23.57
Forward PE16.54
Dividend1.01 (3.95%)
Ex-Dividend DateJun 3, 2025
Volume6
Average Volume13
Open26.00
Previous Close25.25
Day's Range25.60 - 26.00
52-Week Range21.10 - 31.25
Beta0.26
RSI33.96
Earnings DateApr 2, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for a... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1932
Employees 2,736
Stock Exchange London Stock Exchange
Ticker Symbol 0DTF

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.

Financial numbers in EUR Financial Statements